Adcendo ApS Announces First Patient Dosed in Phase I/II ADCElerate1 Trial of ADCE-D01
ADCE-D01 is a first-in-class antibody-drug conjugate (ADC) targeting uPARAP, an endocytic receptor highly overexpressed in mesenchymal cancers including multiple soft tissue sarcoma subtypes
The ADCElerate1 trial will enroll patients in the US and Europe
COPENHAGEN, Denmark, June 10, 2025 /CNW/ -- Adcendo, a clinical-stage biotech company pioneering the development of first and best-in-class ADCs for cancers with a high unmet medical need, today announced that the first patient has been dosed in the Phase I/II ADCElerate1 clinical trial evaluating ADCE-D01 in patients with metastatic and/or unresectable soft tissue sarcoma (STS). The patient was dosed at The Memorial Sloan Kettering Cancer Center in New York.
ADCElerate1 (NCT06797999) is a first-in-human Phase I/II multicenter, open-label, dose escalation and expansion study evaluating ADCE-D01 as a monotherapy in patients with metastatic and/or unresectable STS. The primary objective of the study is to evaluate the safety and tolerability of ADCE-D01. The secondary objectives are to characterize the pharmacokinetics and to evaluate the preliminary efficacy of ADCE-D01. The study will recruit in the US and Europe with the European clinical trial application recently approved (EUCT number: 2024-516900-41-00).
Dr. Lone Ottesen, Chief Medical Officer of Adcendo, said: "The dosing of the first patient in the ADCElerate1 study is a major milestone for both Adcendo and for the uPARAP program and we are excited to evaluate ADCE-D01's potential benefit for patients with advanced STS. uPARAP is a highly attractive target for the development of an ADC in mesenchymal cancers, as it is highly overexpressed in multiple STS subtypes, has unique internalization properties, and shows only very low expression in healthy tissues."
Professor Robert Maki, MD, PhD, Sarcoma Oncologist and Early Drug Development Specialist at the Department Musculoskeletal Cancers and Condition, in the Memorial Sloan Kettering Cancer Center, New York, NY, commented: "We are very pleased to be working with Adcendo to develop ADCE-D01 for the many advanced STS patients who currently have very limited treatment options. ADCs have already made a significant impact across the therapeutic landscape, and we are pleased to be able to bring this exciting treatment modality to our sarcoma patients."
About ADCE-D01
ADCE-D01 is an antibody-drug conjugate (ADC) targeting the uPARAP receptor. uPARAP is a continuously recycling endocytic receptor involved in collagen homeostasis. uPARAP exhibits a restricted expression profile in healthy tissues but is highly upregulated in multiple mesenchymal cancers, including STS, bone sarcoma, GIST, as well as mesothelioma and glioblastoma. ADCE-D01 is a first-in-class pan-mesenchymal cancer targeting ADC in phase 1/2 clinical development.
Adcendo is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts. The company is developing a pipeline of first-in-class antibody-drug conjugates (ADCs) targeting cancers with high unmet medical needs. Led by a team of industry veterans with a track record of advancing multiple ADCs to approval, Adcendo integrates novel targets, optimized linker-payload combinations, and a rationally designed development strategy to drive next-generation cancer therapies. For further information, please visit www.adcendo.com or follow the company on LinkedIn.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
an hour ago
- Cision Canada
Media Advisory - Simultaneous launch of Canadian space technologies Français
LONGUEUIL, QC, June 21, 2025 /CNW/ - Several technologies funded by the Canadian Space Agency under the Space Technology Development Program will be launched into space by SpaceX. These projects are a testament to Canada's leadership in space innovation. EarthDaily Analytics will use high-precision thermal imagers to monitor plant transpiration. The data collected could help farmers make decisions about irrigation, fertilization and crop rotation. It could also provide precise information about areas at greatest risk of wildfires, in order to protect our communities. INO provided infrared cameras as part of this project. Galaxia will launch its first satellite, MÖBIUS-1, a software-defined satellite designed to carry various types of Earth observation sensors. The MÖBIUS constellation could be used for a variety of applications, such as defence, environmental monitoring, agriculture, infrastructure, maritime operations and transportation. GHGSat will add two satellites to its commercial constellation, bringing the company's total to 13 methane detection satellites and one CO 2 detection satellite. Mission Control will test its onboard artificial intelligence (AI) software and machine learning operations system SpacefarerAI™ in partnership with Spire Global. Their Persistence mission aims to show how AI can analyze satellite images directly in space, thereby eliminating the need to send all data to Earth for processing. Xona Space Systems will test Pulsar, a demonstration satellite designed to validate a new generation of satellite navigation from low Earth orbit. This technology could improve precision and reliability of positioning services, including in urban areas, remote areas and the Arctic. Also contributing to the GHGSat and EarthDaily Analytics satellites are ABB 's business unit in Quebec, supplying sophisticated optical sensors, and Xiphos Systems, providing high-performance onboard processors. These innovations demonstrate the ability of Canadian companies to develop innovative technologies that meet the needs of the space program and have strong commercial potential. Media who wish to speak with a Canadian Space Agency expert or a representative from one of these Canadian companies are asked to contact the Media Relations Office.
Cision Canada
2 hours ago
- Cision Canada
Statement by Prime Minister Carney on National Indigenous Peoples Day Français
OTTAWA, ON, /CNW/ - "In my first months as Prime Minister, I have been grateful for the opportunity to meet with First Nations, Inuit, and Métis, and I recognize there is much more work to do together. "The government will work in full partnership with Indigenous Peoples – advancing shared priorities such as health care, food security, housing, education, economic prosperity, conservation, climate action, and emergency management to build a better future. Indigenous partnership is a critical component of the One Canadian Economy Act, and shared leadership with First Nations, Inuit, and Métis will be pivotal to the success of building major projects in Canada. "We will move forward together on the Truth and Reconciliation Commission's Calls to Action, the National Inquiry into Missing and Murdered Indigenous Women and Girls' Calls for Justice, and the implementation of the United Nations Declaration on the Rights of Indigenous Peoples Act. "Supporting Indigenous communities, advancing self-determination, implementing treaties, and creating generational wealth and prosperity are central to our commitment to advancing reconciliation. Through initiatives like the Indigenous Loan Guarantee Program, we're addressing the historical, systemic, and economic barriers that have prevented Indigenous Peoples from participating in – and benefitting from – economic opportunities, particularly in the natural resource sector. "Today, on National Indigenous Peoples Day, and every day, we honour the enduring histories, cultures, and contributions of First Nations, Inuit, and Métis, and we reaffirm our partnership in reconciliation. Together, we can build a better future, a stronger economy, and a legacy that future generations can inherit and carry forward."
Cision Canada
4 hours ago
- Cision Canada
Statement by Minister Valdez to mark National Indigenous Peoples Day Français
OTTAWA, ON, /CNW/ - The Honourable Rechie Valdez, Minister of Women and Gender Equality and Secretary of State (Small Business and Tourism), made the following statement: "Today, I join communities across the country in celebrating National Indigenous Peoples Day. "This is a time to honour the rich histories, vibrant cultures and enduring contributions of First Nations, Inuit, and Métis. From coast to coast to coast, we celebrate the strength, resilience, and leadership of Indigenous communities. "Today, more than 50,000 small businesses are majority-owned by Indigenous entrepreneurs. Indigenous-led businesses are fuelling economic growth and uplifting communities across the country. "In 2023 alone, Indigenous tourism operators generated an estimated 34,700 jobs and billions of dollars in economic activity. These numbers tell a powerful story of resilience and innovation and highlight the vital role Indigenous businesses play in our tourism economy. "As Minister of Women and Gender Equality, I am committed to supporting Indigenous-led efforts to end gender-based violence. Through the National Action Plan to End Gender-Based Violence and the Federal Pathway to Address Missing and Murdered Indigenous Women, Girls and 2SLGBTQQIA+ Peoples, our government is working in partnership with First Nations, Inuit and Métis communities to develop policies and fund programs to end the national crisis facing Indigenous women, girls and 2SLGBTQQIA+ people. This work is essential to healing, justice and safety for Indigenous women, girls and 2SLGBTQQIA+ people, wherever they live. "Our government is deeply committed to advancing reconciliation and to building lasting partnerships with Indigenous Peoples by supporting entrepreneurs, fostering economic opportunity and building an inclusive economy that leaves no one behind. Stay connected Follow the department on . For easy access to government programs for businesses, download the Canada Business app.
